Skip to main content

Table 1 Demographics and Baseline Disease Characteristics for Patients Who Completed or Discontinued the Study

From: Application of a disease-specific mapping function to estimate utility gains with effective treatment of schizophrenia

Parameter

Patients Who Completed the Study (n = 474)

Patients Who Discontinued (n = 251)

P value Between Groups*

Age, y (mean ± SE)

43.7 ± 0.7

39.3 ± 0.9

<0.0001

Sex

  

0.730

   Female, n (%)

162 (34.2)

89 (35.5)

 

   Male, n (%)

312 (65.8)

162 (64.5)

 

Race

  

0.502

   Caucasian, n (%)

440 (92.8)

231 (92.0)

 

   Black, n (%)

8 (1.7)

8 (3.2)

 

   Asian, n (%)

6 (1.3)

5 (2.0)

 

   Hispanic, n (%)

4 (0.8)

2 (0.8)

 

   Other, n (%)

16 (3.4)

5 (2.0)

 

Diagnosis

  

0.650

   Schizophrenia, n (%)

400 (84.4)

215 (85.7)

 

   Schizoaffective disorder, n (%)

74 (15.6)

36 (14.3)

 
  1. SE indicates standard error. *Chi-square test.